NOVEL RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE

被引：0
|
作者：
Latsabidze, N. [1 ]
机构：
[1] Elizabeth Blackwell Hosp, Tbilisi, Georgia
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1.1.014
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [21] Risk Factors, Mortality and cardiovascular Disease in Patients with Type 2 Diabetes
    Gappa, Birgit
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (01) : 12 - 12
  • [22] Influence of variability in risk factors on cardiovascular disease outcomes in type 2 diabetes mellitus
    Uzokov, Jamol
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023,
  • [23] Cardiovascular disease correlates with traditional risk factors but not with glycemic control in established type 2 diabetes
    Kirkman, MS
    Mccarren, M
    Abraira, C
    Duckworth, W
    DIABETES, 2004, 53 : A77 - A77
  • [24] Association of adiponectin with dietary factors and cardiovascular risk factors in type 2 diabetes mellitus patients
    Attar, Mohammad Javad Hosseinzadeh
    Mohammadi, Somayeh
    Karimi, Mehrdad
    Hosseinnezhad, Arash
    Hosseini, Seyed Hossein
    Eshraghian, Mohammad Reza
    Jafari, Nazila
    Rahmani, Mazaher
    Karimi, Farzaneh
    Nezhad, Mohammad Kamali
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (01) : 3 - 7
  • [25] Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
    Wanner, Christoph
    Lachin, John M.
    Inzucchi, Silvio E.
    Fitchett, David
    Mattheus, Michaela
    George, Jyothis
    Woerle, Hans J.
    Broedl, Uli C.
    von Eynatten, Maximilian
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    CIRCULATION, 2018, 137 (02) : 119 - 129
  • [26] EMPAGLIFLOZIN FOR PATIENTS IN THE NETHERLANDS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE: A BUDGET IMPACT MODEL
    Voorhaar, M.
    Nurkanovic, L.
    Ustyugova, A., V
    Dvortsin, E.
    Postma, M. J.
    VALUE IN HEALTH, 2018, 21 : S124 - S124
  • [27] Type 2 diabetes mellitus is an independent predictor of hand grip strength in patients with established cardiovascular disease
    Larcher, Barbara
    Vonbank, Alexander
    Mader, Arthur
    Maechler, Maximilian
    Sprenger, Lukas
    Mutschlechner, Beatrix
    Benda, Magdalena
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 197 - 197
  • [28] Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2
    Verbovoy, A. F.
    Pashentseva, A. V.
    Verbovaya, N. I.
    Madyanov, I. V.
    Sharonova, L. A.
    Galkin, R. A.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (08) : 113 - 117
  • [29] Type 2 Diabetes Mellitus Is an Independent Predictor of Hand Grip Strength in Patients with Established Cardiovascular Disease
    Larcher, Barbara
    Vonbank, Alexander
    Mader, Arthur
    Maechler, Maximilian
    Sprenger, Lukas
    Mutschlechner, Beatrix
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2021, 70
  • [30] Cardiovascular risk factors in patients with type 2 diabetes mellitus treated in an outpatient clinic
    Paola Garza-Lopez, Elisa
    Silva-Ruiz, Rosendo
    Vicente Rodriguez-Perez, Carlos
    SALUD PUBLICA DE MEXICO, 2017, 59 (06): : 604 - 605
12345